We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
INDV

Price
32.75
Stock movement up
+0.98 (3.08%)
Company name
Indivior PLC Ordinary Shares
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
4.09B
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
2.90%
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
11.92
PEG
-
EPS growth
-
1 year return
213.25%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-11-21

DIVIDENDS

INDV does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

FINANCIALS

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)2.75

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash445.00M
Net receivables272.00M
Total current assets922.00M
Goodwill0.00
Intangible assets2.00M
Property, plant and equipment0.00
Total assets1.42B
Accounts payable215.00M
Short/Current long term debt52.00M
Total current liabilities965.00M
Total liabilities1.62B
Shareholder's equity0.00
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open31.37
Daily high33.00
Daily low31.23
Daily Volume2.23M
All-time high32.75
1y analyst estimate36.71
Beta1.12
EPS (TTM)-
Dividend per share0.95
Ex-div date16 Jun 2016
Next earnings date12 Feb 2026

Downside potential

Loading...
Downside potential data
INDVS&P500
Current price drop from All-time high-6.93%-2.23%
Highest price drop-69.89%-19.00%
Date of highest drop11 Oct 20248 Apr 2025
Avg drop from high-39.84%-2.73%
Avg time to new high26 days6 days
Max time to new high226 days89 days
COMPANY DETAILS
INDV (Indivior PLC Ordinary Shares) company logo
Marketcap
4.09B
Marketcap category
Mid-cap
Description
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Employees
1030
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
Semi-annual
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...